Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy.
Fiore G, Weckwarth W, Paetzold K, Albertí Servera L, Gies M, Rosenhauer J, Antoniolli M, Nassiri S, Schmeing S, Dettling S, Soni B, Majety M, Krug AB, Hoves S, Wolf MJ.
Fiore G, et al. Among authors: wolf mj.
Front Immunol. 2024 Nov 7;15:1433119. doi: 10.3389/fimmu.2024.1433119. eCollection 2024.
Front Immunol. 2024.
PMID: 39575246
Free PMC article.